Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions

Crohn DiseaseUlcerative ColitisInflammatory Bowel Diseases

Interventions

OTHER

Resistant Starch

7.5 g resistant starch/m2 oral consumption

OTHER

Placebo

Placebo oral consumption of food-grade cornstarch

Trial Locations (1)

Children's Hospital of Eastern Ontario, Ottawa

All Listed Sponsors

lead

Children's Hospital of Eastern Ontario

OTHER